http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2416690-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf3e7d444112ff6e45ea360315a166d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-017
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
filingDate 1978-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a47bfdab035a08002a63836d920639a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72650e6baab53cda95e268b2b0cd9e6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699896d9b647fd69cf794b4340357ea0
publicationDate 1979-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2416690-A1
titleOfInvention MEDICINAL PRODUCT FOR THE TREATMENT OF RHEUMATISMAL DISEASES AND ITS PREPARATION METHOD
abstract at. Anti-rheumatic-anti-inflammatory drug. b. It consists of a protein hydrolyzate of normal horse serum, in the form of a clear or slightly opalescent solution, with a pH between 6 and 8, with a protein content between 1.5 and 4.5 mg / ml and in equal proportion of components having a molecular weight between 150,000 and 200,000 and components having a molecular weight between 4,000 and 10,000. c. Treatment of rheumatic diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2484651-A1
priorityDate 1978-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-186665-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 21.